In 2014, a nomination was received to establish a stem cell transplantation service for the treatment of three auto-immune diseases: severe systemic scleroderma, systemic lupus erythematosus and multiple sclerosis. The Committee considered that further advice on this technology should be sought and the nomination was referred to the former HealthPACT.
In 2015, a nomination was received for the use of bronchial thermoplasty, a technology that specifically targets airway smooth muscle for radiofrequency ablation. Its proposed use is in the treatment of severe persistent asthma. In 2016, an update was submitted that provided a summary of recent evidence.
In 2017, a nomination was received to support the establishment of a cellular immunotherapy service. This service is proposed for the manufacture of cellular therapeutics and the treatment of patients requiring these products.
In 2017, a nomination was received for a single use dialyser for use in home renal dialysis machines.
In 2017, a nomination was received to establish a new hub and spoke clinic model for the management of patients with neurofibromatosis (NF).
The Committee advised the technology was not new to the NSW public system, rather the combination of two imaging modalities.
Considered to be an Information and Communications Technology.
Technology was not approved by the Therapeutic Goods Association and was unavailable in NSW at the time of application.
The Committee advised the technology was not new to the NSW public system.
This technology was not a diagnostic or therapeutic technology. Referred to HealthShare.
Considered to be an Information and Communications Technology. Referred to eHealth.
The Committee advised the technology was not new to the NSW public system. Requested the district raise this during annual service agreement negotiations with the Ministry.
In 2018, an update was received for a closed loop insulin pump which was the subject of a clinical trial. It is anticipated the results of the trial will be published in late 2019.
In 2019, an update was received on the use of combined MRI images for radiotherapy treatment instead of CT images. This was included in the scope for a planned evidence review on diagnostic imaging to be completed by the Health Technology Reference Group.
In 2019, an update was received for a non-invasive hemodynamic monitor which measures cardiac output and cardiac index to assess the severity of heart failure.
In 2018, an update was received for a laser scanner and robot carver to replace traditional plaster casting. The robot has the capacity to produce orthoses for other healthcare services that have the appropriate scanner and software in place.
In 2019, an update was received for an electroretinogram which may take digital photographs of the retina for transfer to a specialist centre to be evaluated. This could improve access for patients in rural and remote areas.
In 2019, an update was received for software used on a standard linear accelerator to assess prostate position during radiotherapy for treatment of prostate cancer.
In 2019, an update was received on whole genome sequencing which may be used to diagnose different forms of mitochondrial disease.
The Committee advised the technology was not new to the NSW public system. Referred to HealthShare.